Telecom & Wireless
The Worst Stocks Of The Week (SVU, WMT, MRK, VZ, S, T, AAPL)
Published:
Last Updated:
| S&P 500 WEEK: BOTTOM 10 (07 JAN-13 JAN) | Ticker | Weekly Price Change (%) | Close Price 13Jan11 | Close Price 07Jan11 | Market Cap($Mil) |
| SUPERVALU INC. | SVU | -13.4 | 7.50 | 8.66 | 1591.3 |
| Merck & Co Inc. | MRK | -7.1 | 34.69 | 37.35 | 106875.8 |
| RadioShack Corp | RSH | -6.6 | 17.14 | 18.36 | 1951.0 |
| American International Group Inc | AIG | -6.5 | 57.19 | 61.18 | 38439.6 |
| Advanced Micro Devices Inc | AMD | -6.5 | 8.26 | 8.83 | 5631.4 |
| Monster Worldwide Inc. | MWW | -6.2 | 23.51 | 25.07 | 3057.1 |
| Washington Post Co | WPO | -4.8 | 421.30 | 442.56 | 3035.9 |
| Omnicom Group Inc. | OMC | -4.6 | 44.84 | 47.00 | 13507.6 |
| Sprint Nextel Corp | S | -4.3 | 4.48 | 4.68 | 13225.2 |
| Intuit Inc. | INTU | -4.2 | 46.36 | 48.39 | 14399.9 |
Source: Capital IQ
Shares of grocery store giant Supervalu (NYSE: SVU) collapsed as the firm’s earnings were well below expectations. High commodities prices and competition from big box retailers such as Wal-Mart (NYSE: WMT) have finally caught up to Supervalu. The problems are not going to go away. The prices of agricultural products from corn to soy beans have reached all time highs. Supervalu is not going to be able to pass all of those costs of goods on to its customers.
Merck (NYSE: MRK) shares fell as it joined other large pharmaceutical companies which have been unable to replace their aging blockbuster drugs with new ones. Trials for anticlotting drup vorapaxar did not show promising results. Merck believed vorapaxar would eventually have annual sales of $5 billion. Now, vorapaxar may never produce any revenue at all. According to Bloomberg, “All participants will stop taking the drug in the trial of 13,000 patients who began the medicine at the time of a heart attack or chest pain, researchers at Brigham & Women’s Hospital in Boston and the Duke Clinical Research Institute in Durham, North Carolina, said today. A second study, of 26,500 patients with prior heart problems, will be stopped for the 25 percent who had suffered a stroke.”
Sprint-Nextel (NYSE: S) shares dropped over 4% for the week. It has occurred to investors now that the Apple (NASDAQ: AAPL) iPhone will be sold by Verizon Wireless (NYSE: VZ) and AT&T (NYSE: T), Sprint subscribers will continue to migrate to competitors to get the superphone. Sprint’s WiMax 4G service is about to be challenged by LTE technology from AT&T and Verizon. Sprint has been painted into a corner.
Douglas A. McIntyre
Smart Investors Are Quietly Loading Up on These “Dividend Legends” (Sponsored)
If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.
Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
